MCP1 -2518 Polymorphism and chronic obstructive pulmonary disease in Taiwanese men

Experimental Lung Research

Volumn 36, Issue 5, 2010, Pages 277-283

  Liu, Shih Feng ^a   Wang, Chin Chou ^a   Fang, Wen Feng ^a   Chen, Yung Che ^a   Lin, Meng Chih ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Chronic obstructive pulmonary disease; MCP1 2518 polymorphism; Plasma MCP 1

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FORCED EXPIRATORY VOLUME; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHEMOKINE CCL2; CHI-SQUARE DISTRIBUTION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FORCED EXPIRATORY VOLUME; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINEAR MODELS; MALE; MEN'S HEALTH; MIDDLE AGED; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; RISK FACTORS; SMOKING; TAIWAN; VITAL CAPACITY;

EID: 77952831888     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.3109/01902140903575989     Document Type: Article

References (29)

1. Lander ES, Schork NJ: Genetic dissection of complex traits. Science. 1994;265:2037-2048.
2. Joos L, Pare PD, Sandford AJ: Genetic risk factors of chronic obstructive pulmonary disease. Swiss Med Wkly. 2002;132: 27-37. (Pubitemid 34266546)
3. Shapiro SD: The macrophage in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160:S29-S32.
4. Barnes PJ: Chronic obstructive pulmonary disease. N Engl J Med. 2000;343:269-280.
5. Keatings VM, Barnes PJ: Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. Am J Respir Crit Care Med. 1997;155:449-453
6. de Boer WI, Sont JK, van Schadewijk A, Stolk J, van Krieken JH, Hiemstra PS: Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD. J Pathol. 2000;190:619-626.
7. Capelli A, Di-Stefano A, Gnemmi I, Balbo P, Cerutti CG, Balbi B, Lusuardi M, Donner CF: Increased MCP-1 and MIP-1beta in bronchoalveolar lavage fluid of chronic bronchitics. Eur Respir J. 1999;14:160-165.
8. Traves SL, Culpitt SV, Russell RE, Barnes PJ, Donnelly LE: Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD. Thorax. 2002;57:590-595.
9. Lee JS, Rosengart MR, Kondragunta V, Zhang Y, McMurray J, Branch RA, Choi AM, Sciurba FC: Inverse association of plasma IL-13 and inflammatory chemokines with lung function impairment in stable COPD: a cross-sectional cohort study. Respir Res. 2007;8:64.
10. Liu SF, Chin CH, Wang CC, Lin MC: Correlation between serum biomarkers and BODE index in patients with stable COPD. Respirology. 2009;14:999-1004.
11. Rovin BH, Lu L, Saxena R: A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun. 1999;259:344-348.
12. Szalai C, Kozma GT, Nagy A, Bojszkó A, Krikovszky D, Szabó T, Falus A: Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity. J Allergy Clin Immunol. 2001;108:375-381.
13. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J: Global Initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176: 532-555.
14. Solé X, Guinó E, Valls J, Iniesta R, Moreno V: SNPstats:a web tool for the analysis of association studies. Bioinformatics. 2006;22:1928-1929.
15. Baggiolini M: Chemokines and leukocyte traffic. Nature. 1998;392:565-568
16. Adcock K, Hedberg C, Loggins J, Kruger TE, Baier RJ: The TNF-alpha - 308, MCP-1 - 2518 and TGF-beta1 + 915 poly-morphisms are not associated with the development of chronic lung disease in very low birth weight infants. Genes Immun. 2003;4:420-426.
17. Iwai N, Kajimoto K, Kokubo Y, Okayama A, Miyazaki S, Nonogi H, Goto Y, Tomoike H: Assessment of genetic effects of polymorphisms in the MCP-1 gene on serum MCP-1 levels and myocardial infarction in Japanese. Circ J. 2006;70:805-809.
18. Cho ML, Kim JY, Ko HJ, Kim YH, Kim WU, Cho CS, Kim HY, Hwang SY: The MCP-1 promoter - 2518 in Behcet's disease: correlation between allele types, MCP-1 production and clinical symptoms among Korean patients. Autoimmunity. 2004;37:77-80.
19. Cermakova Z, Petrkova J, Arakelyan A, Drabek J, Mrazek F, Lukl J, Petrek M: The MCP-1 - 2518 (A to G) single nucleotide polymorphism is not associated with myocardial infarction in the Czech population. Int J Immunogenet. 2005;32:315-318.
20. Nahon P, Sutton A, Rufat P, Faisant C, Simon C, Barget N, Trinchet JC, Beaugrand M, Gattegno L, Charnaux N: Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study. Eur J Gastroenterol Hepatol. 2007;19:425-431.
21. Inadera H, Egashira K, Takemoto M, Ouchi Y, Matsushima K: Increase of circulating levels of monocyte chemoattractant protein-1 with aging. J Interferon Cytokine Res. 1999;19: 1179-1182.
22. Gerli R, Monti D, Bistoni O, Mazzone AM, Peri G, Cossarizza A, Di Gioacchino M, Cesarotti ME, Doni A, Mantovani A, Franceschi C, Paganelli R: Chemokines, STNF-RS and sCD30 serum levels in healthy aged people and centenarians. Mech Ageing Dev. 2000;121:37-46.
23. Reich D, Patterson N, Ramesh V, De Jager PL, McDonald GJ, Tandon A, Choy E, Hu D, Tamraz B, Pawlikowska L, Wassel-Fyr C, Huntsman S, Waliszewska A, Rossin E, Li R, Garcia M, Reiner A, Ferrell R, Cummings S, Kwok PY, Harris T, Zmuda JM, Ziv E: Health, Aging and Body Composition (Health ABC) Study: Admixture mapping of an allele affecting interleukin 6 soluble receptor and interleukin 6 levels. Am J Hum Genet. 2007;80:716-726.
24. Lazarus R, Klimecki WT, Palmer LJ, Kwiatkowski DJ, Silverman EK, Brown A, Martinez F, Weiss ST: Single-nucleotide polymorphisms in the interleukin-10 gene: differences in frequencies, linkage disequilibrium patterns, and haplotypes in three United States ethnic groups. Genomics. 2002;80:223-228.
25. Delaney NL, Esquenazi V, Lucas DP, Zachary AA, Leffell MS: TNF-alpha, TGF-beta, IL-10, IL-6, and INF-gamma alleles among African Americans and Cuban Americans. Report of the ASHI Minority Workshops: part IV. Hum Immunol. 2004;65:1413-1419.
26. Zhang X, Han Y, Kang J, Yan C: A monocyte chemoattractant protein-1 gene polymorphism is not associated with coronary artery disease in a Han Chinese population. Clin Chim Acta. 2009;403:241-243.
27. Samnegård A, Hulthe J, Silveira A, Ericsson CG, Hamsten A, Eriksson P: Gender specific associations between matrix metal-loproteinases and inflammatory markers in post myocardial infarction patients. Atherosclerosis. 2009;202:550-556.
28. Yada-Hashimoto N, Nishio Y, Ohmichi M, Hayakawa J, Mabuchi S, Hisamoto K, Nakatsuji Y, Sasaki H, Seino-Noda H, Sakata M, Tasaka K, Murata Y: Estrogen and raloxifene inhibit the monocytic chemoattractant protein-1-induced migration of human monocytic cells via nongenomic estrogen receptor alpha. Menopause. 2006;13:935-941.
29. Park KS, Ahn KJ, Kim BJ, Kim HJ, Yoo SM, Kim JY, Lee KH, Baik HW, Lee SK: Circulating concentrations of monocyte chemoattractant protein-1 are associated with menopause status in Korean women. Clin Chim Acta. 2009;403:92-96